News

The drug will now be available to patients with type 2 diabetes who do not exhibit evidence of heart disease but who may show one other risk factors

The researchers used a mouse model to show that the parathyroid hormone related peptide derived from bone forming cells is a potent peptide for bone formation. The investigators

The results of the landmark study showed that one year after initial treatment 84% of patients were “very much improved” or “much improved” according to the global aesthetic

DOV 216303 is known as a triple reuptake inhibitor, meaning that it inhibits reuptake of the three neurotransmitters, most closely linked to depression. This novel combination of properties

This proof-of-concept trial will initially enroll up to 15 patients with advanced solid tumors to establish the maximum tolerated dose of PXD101 used in combination with 5-fluorouracil (5-FU),

Siga’s efforts will specifically aid the US Air Force Special Operations Command in its use of computational biology to design and develop specific countermeasures against the biological threat

The one-year trial is expected to include 1,900 women with postmenopausal osteoporosis. The trial, known as Motion, is a non-inferiority study that will compare the efficacy and safety

Pentacel vaccine is the first DTaP-based combination vaccine candidate for use in infants in the US that includes both polio and Hib vaccine components. The vaccine is already

This study will enroll 300 patients with moderate to severe acne at 20 investigational centers throughout the US. The study design will evaluate three dosage strengths of incyclinide